UMCG Cardiology Researchers partner EHRA-PATHS: A multinational AF trial funded by Horizon 2020

The EHRA-PATHS is a project funded by  the European Union’s Horizon 2020 research and innovation program. The project aims to transform and improve the clinical practice in the field of AF to holistic, inclusive and personalised treatment strategies.

Among the researchers at UMCG,  principal investigators prof dr. Isabelle van Gelder, prof. dr. Michiel Rienstra and the PhD student Colinda Deutekomn will be involved in EHRA-PATHS working on three areas:

·         Clinical and health economic evaluation of new care pathways

·         Communication, dissemination, and implementation into guidelines

·         Project management

Within a period of 60 months and with the collaboration of partners in 11 countries, the project intends to change the single-disease focused approach to a multi-factorial approach considering multimorbidity, polypharmacy, and sex. This transformation will lead to an estimated reduction of € 20 billion in the yearly European healthcare burden of multimorbid, elderly AF patients (>65 years of age).